List of Chapters/Sections(Table Of Content)
1 Study Coverage
1.1 Immunoinformatics Revenue in Immunoinformatics Business (2017-2022) & (US$ Million) Introduction
1.2 Global Immunoinformatics Outlook 2017 VS 2022 VS 2028
1.2.1 Global Immunoinformatics Market Size for the Year 2017-2028
1.2.2 Global Immunoinformatics Market Size for the Year 2017-2028
1.3 Immunoinformatics Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Immunoinformatics in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Immunoinformatics Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Immunoinformatics Market Dynamics
1.4.1 Immunoinformatics Industry Trends
1.4.2 Immunoinformatics Market Drivers
1.4.3 Immunoinformatics Market Challenges
1.4.4 Immunoinformatics Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Immunoinformatics by Type
2.1 Immunoinformatics Market Segment by Type
2.1.1 Cancer Diagnosis & Therapy
2.1.2 Reverse Vaccinology
2.1.3 Immune System Modeling
2.2 Global Immunoinformatics Market Size by Type (2017, 2022 & 2028)
2.3 Global Immunoinformatics Market Size by Type (2017-2028)
2.4 United States Immunoinformatics Market Size by Type (2017, 2022 & 2028)
2.5 United States Immunoinformatics Market Size by Type (2017-2028)
3 Immunoinformatics by Application
3.1 Immunoinformatics Market Segment by Application
3.1.1 Allergy Prediction Databases
3.1.2 Analysis Resource Database
3.1.3 International Immunogenetics System
3.1.4 The Ontology of Immune Epitopes
3.1.5 Immune Epitope Database
3.2 Global Immunoinformatics Market Size by Application (2017, 2022 & 2028)
3.3 Global Immunoinformatics Market Size by Application (2017-2028)
3.4 United States Immunoinformatics Market Size by Application (2017, 2022 & 2028)
3.5 United States Immunoinformatics Market Size by Application (2017-2028)
4 Global Immunoinformatics Competitor Landscape by Company
4.1 Global Immunoinformatics Market Size by Company
4.1.1 Top Global Immunoinformatics Companies Ranked by Revenue (2021)
4.1.2 Global Immunoinformatics Revenue by Player (2017-2022)
4.2 Global Immunoinformatics Concentration Ratio (CR)
4.2.1 Immunoinformatics Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Immunoinformatics in 2021
4.2.3 Global Immunoinformatics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Immunoinformatics Headquarters, Revenue in Immunoinformatics Business (2017-2022) & (US$ Million) Type
4.3.1 Global Immunoinformatics Headquarters and Area Served
4.3.2 Global Immunoinformatics Companies Revenue in Immunoinformatics Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Immunoinformatics Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Immunoinformatics Market Size by Company
4.5.1 Top Immunoinformatics Players in United States, Ranked by Revenue (2021)
4.5.2 United States Immunoinformatics Revenue by Players (2020, 2021 & 2022)
5 Global Immunoinformatics Market Size by Region
5.1 Global Immunoinformatics Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Immunoinformatics Market Size by Region (2017-2028)
5.2.1 Global Immunoinformatics Market Size by Region: 2017-2022
5.2.2 Global Immunoinformatics Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Immunoinformatics Market Size YoY Growth 2017-2028
6.1.2 North America Immunoinformatics Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Immunoinformatics Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Immunoinformatics Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Immunoinformatics Market Size YoY Growth 2017-2028
6.3.2 Europe Immunoinformatics Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Immunoinformatics Market Size YoY Growth 2017-2028
6.4.2 Latin America Immunoinformatics Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Immunoinformatics Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Immunoinformatics Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 EpiVax
7.1.1 EpiVax Company Details
7.1.2 EpiVax Business Overview
7.1.3 EpiVax Immunoinformatics Introduction
7.1.4 EpiVax Revenue in Immunoinformatics Business (2017-2022)
7.1.5 EpiVax Recent Development
7.2 Novozymes Biopharma
7.2.1 Novozymes Biopharma Company Details
7.2.2 Novozymes Biopharma Business Overview
7.2.3 Novozymes Biopharma Immunoinformatics Introduction
7.2.4 Novozymes Biopharma Revenue in Immunoinformatics Business (2017-2022)
7.2.5 Novozymes Biopharma Recent Development
7.3 ioGenetics
7.3.1 ioGenetics Company Details
7.3.2 ioGenetics Business Overview
7.3.3 ioGenetics Immunoinformatics Introduction
7.3.4 ioGenetics Revenue in Immunoinformatics Business (2017-2022)
7.3.5 ioGenetics Recent Development
7.4 International Society of Vaccines
7.4.1 International Society of Vaccines Company Details
7.4.2 International Society of Vaccines Business Overview
7.4.3 International Society of Vaccines Immunoinformatics Introduction
7.4.4 International Society of Vaccines Revenue in Immunoinformatics Business (2017-2022)
7.4.5 International Society of Vaccines Recent Development
7.5 IMGT
7.5.1 IMGT Company Details
7.5.2 IMGT Business Overview
7.5.3 IMGT Immunoinformatics Introduction
7.5.4 IMGT Revenue in Immunoinformatics Business (2017-2022)
7.5.5 IMGT Recent Development
7.6 Dassault Systemes
7.6.1 Dassault Systemes Company Details
7.6.2 Dassault Systemes Business Overview
7.6.3 Dassault Systemes Immunoinformatics Introduction
7.6.4 Dassault Systemes Revenue in Immunoinformatics Business (2017-2022)
7.6.5 Dassault Systemes Recent Development
7.7 Certara
7.7.1 Certara Company Details
7.7.2 Certara Business Overview
7.7.3 Certara Immunoinformatics Introduction
7.7.4 Certara Revenue in Immunoinformatics Business (2017-2022)
7.7.5 Certara Recent Development
7.8 Chemical Computing Group
7.8.1 Chemical Computing Group Company Details
7.8.2 Chemical Computing Group Business Overview
7.8.3 Chemical Computing Group Immunoinformatics Introduction
7.8.4 Chemical Computing Group Revenue in Immunoinformatics Business (2017-2022)
7.8.5 Chemical Computing Group Recent Development
7.9 Compugen
7.9.1 Compugen Company Details
7.9.2 Compugen Business Overview
7.9.3 Compugen Immunoinformatics Introduction
7.9.4 Compugen Revenue in Immunoinformatics Business (2017-2022)
7.9.5 Compugen Recent Development
7.10 Genedata AG
7.10.1 Genedata AG Company Details
7.10.2 Genedata AG Business Overview
7.10.3 Genedata AG Immunoinformatics Introduction
7.10.4 Genedata AG Revenue in Immunoinformatics Business (2017-2022)
7.10.5 Genedata AG Recent Development
7.11 Insilico Biotechnology AG
7.11.1 Insilico Biotechnology AG Company Details
7.11.2 Insilico Biotechnology AG Business Overview
7.11.3 Insilico Biotechnology AG Immunoinformatics Introduction
7.11.4 Insilico Biotechnology AG Revenue in Immunoinformatics Business (2017-2022)
7.11.5 Insilico Biotechnology AG Recent Development
7.12 Leadscope Inc
7.12.1 Leadscope Inc Company Details
7.12.2 Leadscope Inc Business Overview
7.12.3 Leadscope Inc Immunoinformatics Introduction
7.12.4 Leadscope Inc Revenue in Immunoinformatics Business (2017-2022)
7.12.5 Leadscope Inc Recent Development
7.13 Nimbus Discovery
7.13.1 Nimbus Discovery Company Details
7.13.2 Nimbus Discovery Business Overview
7.13.3 Nimbus Discovery Immunoinformatics Introduction
7.13.4 Nimbus Discovery Revenue in Immunoinformatics Business (2017-2022)
7.13.5 Nimbus Discovery Recent Development
7.14 Strand Life Sciences
7.14.1 Strand Life Sciences Company Details
7.14.2 Strand Life Sciences Business Overview
7.14.3 Strand Life Sciences Immunoinformatics Introduction
7.14.4 Strand Life Sciences Revenue in Immunoinformatics Business (2017-2022)
7.14.5 Strand Life Sciences Recent Development
7.15 Schrodinger
7.15.1 Schrodinger Company Details
7.15.2 Schrodinger Business Overview
7.15.3 Schrodinger Immunoinformatics Introduction
7.15.4 Schrodinger Revenue in Immunoinformatics Business (2017-2022)
7.15.5 Schrodinger Recent Development
7.16 Simulation Plus
7.16.1 Simulation Plus Company Details
7.16.2 Simulation Plus Business Overview
7.16.3 Simulation Plus Immunoinformatics Introduction
7.16.4 Simulation Plus Revenue in Immunoinformatics Business (2017-2022)
7.16.5 Simulation Plus Recent Development
7.17 Rosa & Co
7.17.1 Rosa & Co Company Details
7.17.2 Rosa & Co Business Overview
7.17.3 Rosa & Co Immunoinformatics Introduction
7.17.4 Rosa & Co Revenue in Immunoinformatics Business (2017-2022)
7.17.5 Rosa & Co Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
